After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

For many in the Texas Panhandle, a groundbreaking procedure is offering a new lease on life ... is a minimally invasive treatment for severe or very severe COPD and emphysema.

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Multiple chemicals in cigarette smoke and e-cigarettes alter the function of a key type of lung immune cell. Cigarette ...

The programme – spearheaded by The Academic Respiratory Initiative for Pulmonary Health (Tariph) Centre under LKCMedicine – ...

Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...